Kriti Nutrients quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	247	229	+7.9%
EBITDA	11.8	11.4	+3.9%
EBITDA margin	4.8%	5.0%	−0.2 pts
Profit before tax	11.7	11.9	−1.2%
Net profit	8.9	9.5	−6.0%
EPS	₹1.78	₹1.89	−5.8%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025

Expenses
	247	255	224	213	229	200
	1.7	1.6	1.9	2.4	2.0	1.9
	249	257	226	215	231	202
	201	217	182	175	196	170
	18.2	15.1	17.2	13.8	11.2	7.8
	3.5	−4.1	0.5	−0.8	−1.9	0.8
	4.1	7.3	4.4	4.0	4.1	7.9
	0.2	0.2	0.1	0.1	0.1	0.2
	1.5	1.4	1.4	1.4	1.4	1.4
	8.3	10.8	8.9	9.3	8.2	7.7
	237	248	214	203	219	196
	11.8	9.3	11.5	11.2	11.4	6.1
	10.3	7.9	10.1	9.8	9.9	4.7
Profit
	11.7	9.3	11.9	12.1	11.9	6.4
	11.7	9.3	11.9	12.1	11.9	6.4
	2.8	3.3	2.5	2.9	2.7	1.6
	−0.1	−0.2	0.1	−0.0	−0.1	−0.1
	2.7	3.1	2.6	2.9	2.7	1.5
	−0.1	0.2	−0.1	−0.3	0.3	−0.0
	8.9	6.4	9.2	8.9	9.5	4.9
	9.1	6.2	9.2	9.2	9.2	4.9
	0.0	−0.1	0.1	−0.0	−0.1	−0.1
	8.9	6.3	9.2	8.9	9.4	4.8
	—	—	9.2	—	9.5	—
Per share
	₹1.78	₹1.27	₹1.83	₹1.78	₹1.89	₹0.98
	₹1.78	₹1.27	₹1.83	₹1.78	₹1.89	₹0.98
Other comprehensive income — detail
	0.0	−0.1	0.1	−0.0	−0.1	−0.1
	—	—	—	—	−0.0	—
	0.0	−0.0	−0.1	0.0	0.0	0.1
	−0.0	0.1	−0.0	0.0	0.0	−0.0
	8.9	—	9.2	—	9.5	—
Per share — as-filed variants
	₹1.78	₹1.27	₹1.83	₹1.78	₹1.89	₹0.98
	₹1.78	₹1.27	₹1.83	₹1.78	₹1.89	₹0.98
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	24.3	27.3	24.8	24.5	23.6	21.7
	9.8%	10.7%	11.0%	11.5%	10.3%	10.8%
Adjusted (ex-exceptional items) — derived
	11.7	9.3	11.9	12.1	11.9	6.4
	8.9	6.4	9.2	8.9	9.5	4.9
	₹1.78	₹1.27	₹1.83	₹1.78	₹1.89	₹0.98

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KRITINUT₹64.02

Kriti Nutrients Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersGOKUL HALDER MKPL ROML NKIND SUNDROPMcap ₹321 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	200.1	229.0	212.9	224.3	255.2	247.1
Other Income	1.9	2.0	2.4	1.9	1.6	1.7
Total Income	202.0	231.1	215.4	226.2	256.8	248.8
Expenses
+ Cost of Materials Consumed	169.8	196.0	175.4	181.8	216.9	201.1
+ Purchases of Stock-in-Trade	7.8	11.2	13.8	17.2	15.1	18.2
+ Changes in Inventories	0.8	-1.9	-0.8	0.5	-4.1	3.5
+ Employee Benefit Expense	7.9	4.1	4.0	4.4	7.3	4.1
+ Finance Costs	0.2	0.1	0.1	0.1	0.2	0.2
+ Depreciation & Amortisation	1.4	1.4	1.4	1.4	1.4	1.5
+ Other Expenses	7.7	8.2	9.3	8.9	10.8	8.3
Total Expenses	195.5	219.2	203.2	214.4	247.5	237.0
EBITDA	6.1	11.4	11.2	11.5	9.3	11.8
EBIT	4.7	9.9	9.8	10.1	7.9	10.3
Profit
PBT before Exceptional Items	6.4	11.9	12.1	11.9	9.3	11.7
Pretax Income	6.4	11.9	12.1	11.9	9.3	11.7
+ Current Tax	1.6	2.7	2.9	2.5	3.3	2.8
+ Deferred Tax	-0.1	-0.1	-0.0	0.1	-0.2	-0.1
Tax Expense	1.5	2.7	2.9	2.6	3.1	2.7
+ Share of Associates & JVs	-0.0	0.3	-0.3	-0.1	0.2	-0.1
Net Income	4.9	9.5	8.9	9.2	6.4	8.9
+ Net Income — Continuing Ops	4.9	9.2	9.2	9.2	6.2	9.1
+ Other Comprehensive Income	-0.1	-0.1	-0.0	0.1	-0.1	0.0
Total Comprehensive Income	4.8	9.4	8.9	9.2	6.3	8.9
Net Income to Common	—	9.5	—	9.2	—	—
Per Share
Basic EPS	0.98	1.89	1.78	1.83	1.27	1.78
Diluted EPS	0.98	1.89	1.78	1.83	1.27	1.78
Other Comprehensive Income — detail
+ Other Comprehensive Income	-0.1	-0.1	-0.0	0.1	-0.1	0.0
+ Items NOT to be Reclassified to P&L	—	-0.0	—	—	—	—
+ Tax on Items NOT to be Reclassified	0.1	0.0	0.0	-0.1	-0.0	0.0
+ Tax on Items to be Reclassified	-0.0	0.0	0.0	-0.0	0.1	-0.0
Comprehensive Income — Owners of Parent	—	9.5	—	9.2	—	8.9
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.98	1.89	1.78	1.83	1.27	1.78
Diluted EPS — Continuing Operations	0.98	1.89	1.78	1.83	1.27	1.78
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	21.7	23.6	24.5	24.8	27.3	24.3
Gross Margin %	10.84	10.32	11.52	11.04	10.71	9.82
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	6.4	11.9	12.1	11.9	9.3	11.7
Net Income Adj (tax-effected)	4.9	9.5	8.9	9.2	6.4	8.9
EPS Adj	0.98	1.89	1.78	1.83	1.27	1.78
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	5.0	5.0	5.0	5.0	5.0	5.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Kriti Nutrients quarterly results

Kriti Nutrients (NSE: KRITINUT) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹8.9 crore, down 6.0% from ₹9.5 crore in Q1 FY26 and up 40.2% from ₹6.4 crore in Q4 FY26. Revenue from operations was ₹247 crore, up 7.9% year on year and down 3.2% from the previous quarter.

Q2 FY26 results (a year earlier): 8 November 2025
Q1 FY27 results (the latest): 11 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹8.9 Cr−6.0% vs Q1 FY26+40.2% vs Q4 FY26
Q1 FY27 revenue: ₹247 Cr+7.9% vs Q1 FY26−3.2% vs Q4 FY26
Q1 FY27 operating margin: 4.2%−0.2 pts vs Q1 FY26+1.1 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹8.9 CrRevenue ₹213 Cr
Q1 FY27 EPS (basic): ₹1.78

Questions

When will Kriti Nutrients announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 8 November 2025.

What will Kriti Nutrients' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹8.9 crore and revenue from operations ₹213 crore. The latest quarter, Q1 FY27, had a net profit of ₹8.9 crore and revenue of ₹247 crore.

What were Kriti Nutrients' Q1 FY27 results?

Consolidated net profit was ₹8.9 crore, down 6.0% from ₹9.5 crore in Q1 FY26 and up 40.2% from ₹6.4 crore in Q4 FY26. Revenue from operations was ₹247 crore, up 7.9% year on year and down 3.2% from the previous quarter.

How has Kriti Nutrients' profit changed over the last four quarters?

Net profit by quarter: ₹8.9 crore in Q2 FY26, ₹9.2 crore in Q3 FY26, ₹6.4 crore in Q4 FY26 and ₹8.9 crore in Q1 FY27. That is ₹33.3 crore over the four quarters. Revenue from operations: ₹213 crore, ₹224 crore, ₹255 crore and ₹247 crore.

What was Kriti Nutrients' net profit in FY26?

Consolidated net profit was ₹33.9 crore in FY26 (April 2025–March 2026), down 8.4% from ₹37 crore in FY25.

What was Kriti Nutrients' revenue in FY26?

Revenue from operations was ₹922 crore in FY26 (April 2025–March 2026), up 25.5% from ₹734 crore in FY25.

Where do these Kriti Nutrients figures come from?

From Kriti Nutrients' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.